- Home
- / Immuneoncia Therapeutics
Immuneoncia Therapeutics
Total Funding
$40 M
Immuneoncia Therapeutics Summary
Company Summary
- Overview
- Immuneoncia Therapeutics is a company operating in drug development and antibody engineering for oncology patients. The company is aimed at creating antibodies for different cancer types immunotherapy.
- Type
- Private
- Status
- Active
- Founded
- 2016
- HQ
- Seongnam-si, KR | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Seongnam-si, Gyeonggi-do HQ
Korea (Republic of)
tower 6f, 산15-14 Pangyo-dong, Bundang-gu
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026